Novavax to Host 2nd Annual Analyst and Investor Meeting
Senior management will conduct a series of presentations to update analysts and investors as to the company's recombinant nanoparticle vaccine technology, its RSV program, and its influenza program.
For additional information and registration, please e-mail Novavax@westwicke.com, or call 443-213-0506.
A live webcast link of the presentations will be available via the company website at www.novavax.com under Investor Info/Events. Please allow extra time prior to the webcast to visit the site and download the streaming media software required to listen to the Internet broadcast. The event will be archived on the company's website for 90 days.
Barclay A. PhillipsSVP, Chief Financial Officer and Treasurer Novavax, Inc.240-268-2000